# Terezia Jarosova

> Terezia Jarosova is a seed investor at MultiplexDX (Bratislava) backing SaaS and Real Time. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [MultiplexDX](https://shizune.co/investors/profile/multiplexdx-inc)
- Location: Bratislava, Slovakia (Slovak Republic)
- Total investments: 1
- Last investment: Jun 2022
- Lead investor: 0%
- Last updated: Aug 2026

Terezia Jarosova is a seed investor at MultiplexDX in Bratislava focused on SaaS and Real Time. Terezia joined the Neulogy Ventures team in 2014. She gained her professional experience as an Institutional Relations intern at Sustainalytics in the Netherlands, where she worked on development of both internal and external communication strategies. She honed her analytical skills at a reinsurance company in Bratislava. Terezia holds a Bachelor’sdegree from The Hague University of Applied Sciences.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| SaaS | 1 | 100% |
| Real Time | 1 | 100% |
| Health Care | 1 | 100% |
| Health Diagnostics | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Iluria | Iluria is a digital health company providing support to caregivers and families in ADHD management & treatment decisions. The company utilizes a machine and deep learning-based engine to provide personalized, objective, real-time outputs to physicians through a professional web application and to parents through a cellular app. They targetingthe trial and error treatment process in ADHD patients.Iluria offering a comprehensive SaaS-based solution that provides continuous & passive monitoring, using biomarker data (smart wearable agnostic) and ML analysis. It was founded in 2018 and is based in Hod Hasharon, HaMerkaz, Israel. |  | Seed | Jun 08, 2022 |  |

1 of 1 investments shown.

## About MultiplexDX

VC Fund · Gaithersburg, United States

MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology andhistopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.

5 contacts available at MultiplexDX.

| Name | Title | Profile |
| --- | --- | --- |
| Terezia Jarosova | Board Member | https://shizune.co/investors/profile/terezia-jarosova |
| Pavol Cekan | CEO and Co-founder | https://shizune.co/investors/profile/pavol-cekan |
| Peter Kilian | Chief Operating Officer | https://shizune.co/investors/profile/peter-kilian-3e73 |
| Petra Lipnicka | Chief Strategy Officer | https://shizune.co/investors/profile/petra-lipnicka-c997 |
| Vladimir Wolf | co-founder, executive director | https://shizune.co/investors/profile/vladimir-wolf |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Terezia Jarosova invest in?

Terezia Jarosova invests primarily in SaaS, Real Time and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Terezia Jarosova last invest?

The most recent investment recorded for Terezia Jarosova closed in Jun 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co